News & Updates

Show Multimedia Only
Fruit and vegetable intake lowers endometrial cancer risk

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023

Eating fruits and vegetables may help reduce the risk of endometrial cancer, suggests a recent study, noting that specific kinds of fruits and vegetables must be recommended based on their outstanding bioactive components.

Fruit and vegetable intake lowers endometrial cancer risk

02 Jun 2023
Functional surgery delivers amputation-free benefit in nail unit melanoma

Functional surgery delivers amputation-free benefit in nail unit melanoma

29 May 2023

Patients who have nail unit melanoma (NUM) with a Breslow thickness (BT) of <0.8 mm may benefit from functional surgery, which offers an amputation-sparing advantage, suggests a recent study.

Functional surgery delivers amputation-free benefit in nail unit melanoma

29 May 2023
HCT treatment tied to lower cancer risk, except skin cancer

HCT treatment tied to lower cancer risk, except skin cancer

26 May 2023
12-year review of HK Breast Cancer Registry: Neoadjuvant chemo effective in stage ≥II, HER2-positive and triple-negative dise

12-year review of HK Breast Cancer Registry: Neoadjuvant chemo effective in stage ≥II, HER2-positive and triple-negative disease

26 May 2023 byNatalia Reoutova

A 12-year review of Hong Kong Breast Cancer Registry (HKBCR) records of patients diagnosed with breast cancer in 2006–2017 showed that neoadjuvant chemotherapy (NAC) was effective in tumour downstaging, with one-fifth of patients subsequently achieving pathological complete response (pCR) in the breast and axillary lymph nodes. Patients with HER2-positive (nonluminal) and triple-negative disease were most likely to achieve pCR.

12-year review of HK Breast Cancer Registry: Neoadjuvant chemo effective in stage ≥II, HER2-positive and triple-negative disease

26 May 2023
Serum osteopontin levels predicts response to treatment in unresectable HCC

Serum osteopontin levels predicts response to treatment in unresectable HCC

25 May 2023

Among patients with unresectable hepatocellular carcinoma (HCC) scheduled to receive standard combination therapy with atezolizumab plus bevacizumab, those with high levels of serum osteopontin at baseline are likely to have poor response to treatment, as shown in a study.

Serum osteopontin levels predicts response to treatment in unresectable HCC

25 May 2023
Nonsmoking, asbestos-exposed people still at risk of lung cancer

Nonsmoking, asbestos-exposed people still at risk of lung cancer

25 May 2023